REGENERX BIOPHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Regenerx Biopharmaceuticals Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q1 2023.
  • Regenerx Biopharmaceuticals Inc Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2023 was $57.8K, a 257% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $57.8K +$41.6K +257% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $69.5K +$41.8K +151% Dec 31, 2022 10-Q 2023-05-15
Q3 2022 $75.8K +$37.2K +96.5% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $4.15K -$44.8K -91.5% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $16.2K -$42.6K -72.5% Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $27.7K -$40.6K -59.4% Dec 31, 2021 10-K 2023-04-11
Q3 2021 $38.6K -$38.6K -50% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $49K -$33K -40.3% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $58.8K +$44.5K +310% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $68.2K +$43.8K +179% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $77.2K +$43.1K +127% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $82K +$38.9K +90.3% Jun 30, 2020 10-K 2021-03-02
Q1 2020 $14.4K -$37.3K -72.2% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $24.5K +$24.5K Dec 31, 2019 10-K 2021-03-02
Q3 2019 $34K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $43.1K Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $51.7K Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.